CFIUS determined that However, SARS-CoV pathogens, which bear a genetic similarity to the virus that causes COVID-19, are export-controlled and companies that test them may be “TID U.S. Businesses.”Consequently, many U.S. biotech companies may be “TID U.S. Businesses” due to their maintaining or collecting “sensitive personal data” of U.S. citizens. The COVID-19 pandemic has generated a renewed focus on biotechnology and life sciences companies. the current inability of CFIUS to examine certain non-controlling transactions in a US business that produces, designs, tests, manufactures, fabricates or develops one or more critical technologies. However, SARS-CoV pathogens, which bear a genetic similarity to the virus that causes COVID-19, are export-controlled and companies that test them may be “TID U.S. Businesses.”Consequently, many U.S. biotech companies may be “TID U.S. Businesses” due to their maintaining or collecting “sensitive personal data” of U.S. citizens.
Program requires parties to submit to CFIUS notice of certain foreign investments in US businesses involved in specified critical technologies at least 45 days prior to closing. CFIUS is an interagency committee authorized to review certain transactions involving foreign investment in the United States and certain real estate transactions by foreign persons, in order to determine the effect of such transactions on the national security of the United States. Both technologies are explicitly included in CFIUS’ definition of “critical technology” and thus potentially implicate mandatory filing requirements and impact CFIUS’ view of the risk associated with affected transactions. The Foreign Investment Risk Review Modernization Act of 2018 (“FIRRMA”) authorizes CFIUS, through the issuance of regulations, to mandate filings for covered transactions involving certain U.S. businesses that produce, design, test, manufacture, fabricate, or develop one or more critical technologies. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide. CFIUS Pilot Program Makes Notifications Mandatory for Specific Areas of Critical Technology . The Situation: The U.S. Department of the Treasury ("Treasury Department") recently issued proposed regulations that will alter and in some cases expand the scope of critical technology foreign investments subject to mandatory review by the Committee on Foreign Investment in the United States ("CFIUS" or "Committee"). 1 CFIUS defines “critical technologies” to include (a) defense articles or defense services included on the United States Munitions List (USML) set forth in the International Traffic in Arms Regulations (ITAR) (22 CFR parts 120– 130); (b) items included on the Commerce Control List (CCL) set forth in Supplement No. The regulations, which were released in two parts, became effective on February 13, 2020.
In 2019, CFIUS forced a Chinese owner to divest its majority interest in a Massachusetts-based health tech startup, PatientsLikeMe, due to concerns that the company had maintained health care data on U.S. citizens.Although filing with CFIUS is typically voluntary, there is a Regardless of whether a company is considered a “TID U.S. Business,” acquisitions of CFIUS may appear daunting to investors who have not gone through the review process before. The full language of FIRRMA and related information can be found on theThe Department of the Treasury issued a final rule—On May 20, 2020, CFIUS released a new Case Management System (CMS), which allows easy submission of all transaction-related information through a secure online portal.As of June 1, the CMS portal must be used to file any draft or formal written notice or declaration pursuant to 31 C.F.R. This process will consider both public and classified information, as well as information from the Emerging Technology Technical Advisory Committee and CFIUS. To embed, copy and paste the code into your website or blog:Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure.
CFIUS is an interagency committee authorized to review certain transactions involving foreign investment in the United States and certain real estate transactions by foreign persons, in order to determine the effect of such transactions on the national security of the United States. The proposed rule provides that, except for certain EAR license exceptions,Under CFIUS’s regulations, a filing is mandatory for any transaction that would result in an acquisition, directly or indirectly, by a foreign person of a “substantial interest” (defined as a 25 percent or greater direct or indirect voting interest) in a TID U.S. business by a foreign person in which a certain foreign government has, directly or indirectly, a “substantial interest” (defined as a 49 percent or greater direct or indirect voting interest). CFIUS risk assessments will be an important part of any transaction involving foreign investors in the biotech sector.CFIUS refers to such businesses as “TID U.S. Businesses” (Critical Emerging and foundational technologies have not yet been defined, but will be determined by an interagency process.
Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Steven Terner Mnuchin was sworn in as the 77th Secretary of the Treasury on February 13, 2017. Under ECRA, emerging and foundational technologies are those that are essential to U.S. national security.Many pathogens, toxins and biological processing equipment are export controlled under the EAR and are thus considered “critical technologies.” This includes certain:The Commerce Department has provided guidance stating that the SARS-CoV-2 virus, the underlying virus that causes COVID-19, is not export-controlled under the EAR. Critical Technologies Explained
